Observational studyInternational journal of hematology2025

Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.

Soo Chin Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.